Targeted treatment strategies for concussion.

Author(s):  
Anthony P. Kontos ◽  
Michael W. Collins
2021 ◽  
Author(s):  
Michal Kovac ◽  
Baptiste Ameline ◽  
Sebastian Ribi ◽  
Monika Kovacova ◽  
William Cross ◽  
...  

2016 ◽  
Vol 24 (5) ◽  
pp. 404-411 ◽  
Author(s):  
S. R. Bartlett ◽  
J. O. Wertheim ◽  
R. A. Bull ◽  
G. V. Matthews ◽  
F. M. J. Lamoury ◽  
...  

Author(s):  
Helen J. MacKay ◽  
Victor Rodriguez Freixinos ◽  
Gini F. Fleming

Worldwide, the incidence of endometrial cancer is increasing. Although the prognosis remains good for patients diagnosed with early-stage disease, for those diagnosed with recurrent or metastatic disease, options have been limited, and prognosis is short. Optimizing and identifying new well-tolerated treatments for women living with endometrial cancer is a top priority. A new era is dawning where we are starting to see the integration of clinically relevant genomic and pathologic data to inform and refine treatment strategies for women with endometrial cancer. Here, we focus on reviewing nonimmunotherapy-based targeted treatment options and emerging directions for women with endometrial cancer.


Leukemia ◽  
2018 ◽  
Vol 32 (5) ◽  
pp. 1249-1253 ◽  
Author(s):  
Manja Meggendorfer ◽  
Luca Vincenzo Cappelli ◽  
Wencke Walter ◽  
Claudia Haferlach ◽  
Wolfgang Kern ◽  
...  

2011 ◽  
Vol 2011 ◽  
pp. 1-16 ◽  
Author(s):  
Niki A. Ottenhof ◽  
Roeland F. de Wilde ◽  
Anirban Maitra ◽  
Ralph H. Hruban ◽  
G. Johan A. Offerhaus

Pancreatic cancer is an almost universally lethal disease and despite extensive research over the last decades, this has not changed significantly. Nevertheless, much progress has been made in understanding the pathogenesis of pancreatic ductal adenocarcinoma (PDAC) suggesting that different therapeutic strategies based on these new insights are forthcoming. Increasing focus exists on designing the so-called targeted treatment strategies in which the genetic characteristics of a tumor guide therapy. In the past, the focus of research was on identifying the most frequently affected genes in PDAC, but with the complete sequencing of the pancreatic cancer genome the focus has shifted to defining the biological function that the altered genes play. In this paper we aimed to put the genetic alterations present in pancreatic cancer in the context of their role in signaling pathways. In addition, this paper provides an update of the recent advances made in the development of the targeted treatment approach in PDAC.


2012 ◽  
Vol 165 (5) ◽  
pp. 1246-1259 ◽  
Author(s):  
Jürgen Götz ◽  
Arne Ittner ◽  
Lars M Ittner

Sign in / Sign up

Export Citation Format

Share Document